Lonza Group Ltd

O6Z

Company Profile

  • Business description

    Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

  • Contact

    Muenchensteinerstrasse 38
    Basel4002
    CHE

    T: +41 613168111

    E: [email protected]

    https://www.lonza.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    19,299

Stocks News & Analysis

stocks

2 picks in an undervalued ASX sector

Investors may be too pessimistic about this industry.
stocks

AMD and OpenAI partnership

What does another huge AI deal mean for investors?
stocks

Undervalued ASX founder-led companies

Can this strategy pick the winners?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,244.8011.80-0.13%
CAC 408,049.2174.360.93%
DAX 4024,605.63219.850.90%
Dow JONES (US)46,665.6462.660.13%
FTSE 1009,542.3358.750.62%
HKSE26,829.46128.31-0.48%
NASDAQ22,941.24152.880.67%
Nikkei 22547,734.99215.89-0.45%
NZX 50 Index13,568.4837.190.27%
S&P 5006,740.9726.380.39%
S&P/ASX 2008,947.6010.80-0.12%
SSE Composite Index3,882.7820.250.52%

Market Movers